InvestorsHub Logo
Followers 49
Posts 4907
Boards Moderated 1
Alias Born 01/05/2005

Re: None

Tuesday, 10/31/2006 9:57:16 AM

Tuesday, October 31, 2006 9:57:16 AM

Post# of 42
InPlay
October 31, 2006
8:56AM Lumera: Harvard Medical School researchers to build next generation discovery and diagnostics methods with co's
ProteomicProcessor Biosensor (LMRA) 6.35 : Co announces that Harvard Medical School researchers are now building next generation discovery and diagnostics methods with it's ProteomicProcessor Biosensor. During the past year, Lumera has placed four beta units with highly respected, world renowned research organizations to demonstrate and establish new applications that take advantage of the instrument's unprecedented throughput in a label-free format. Harvard has served as a beta site for Lumera's biosensor platform, the ProteomicProcessor(TM), since mid-2006. The Harvard collaboration is focused on integrating their NAPPA (Nucleic Acid Programmable Protein Array) technology, which provides a simple and cost-effective way to generate a protein biochip, with the ProteomicProcessor(TM) to read and analyze the biochip.